Virbac Sa

Philippe Archimbault

Arthur Donny Strosberg

Ahmed El Hadri

France Pietri-Rouxel

Gérard Leclerc

The invention concerns aryloxypropanolamine derivatives having at least an anti-diabetic and anti-fat activity and their methods of preparation and applications, particularly as human and veterinary medicine and animal food additive. These derivatives comply with the general formula (I) in which Rrepresents one of the following groups: &#x2014;CH&#x2014;, &#x2014;CH&#x2014;CH, &#x2014;CH(CH)&#x2014;CH&#x2014;, &#x2014;C(CH)&#x2550;CH&#x2014;, &#x2014;C(CH)&#x2014;CH&#x2014; or a bond; Q represents: (i) a phenyl radical 3,4-disubstituted alkylene dioxy determining with the phenyl radical, a non-substituted benzodioxane unit, a non-substituted benzodioxol unit, or a 2-substituted benzodioxol unit, (ii) a phenyl radical 3 and/or 4-substituted, by a O&#x2014;(CH)&#x2014;COORgroup, (iii) a condensed polycyclic hydrocarbon comprising at least two condensed cycles, (iv) a cyclic hydrocarbon system, optionally cross-linked, and constituting a cycloalkane comprising 1, 2 or 3 cycles

Growing community of inventors

Monaco, Monaco

Philippe Archimbault